Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The genetic basis of pheochromocytoma and paraganglioma: implications for management.

Shuch B, Ricketts CJ, Metwalli AR, Pacak K, Linehan WM.

Urology. 2014 Jun;83(6):1225-32. doi: 10.1016/j.urology.2014.01.007. Epub 2014 Mar 15. Review.

2.

Familial pheochromocytomas and paragangliomas.

King KS, Pacak K.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):92-100. doi: 10.1016/j.mce.2013.07.032. Epub 2013 Aug 7. Review.

3.

Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.

Fishbein L, Orlowski R, Cohen D.

J Clin Hypertens (Greenwich). 2013 Jun;15(6):428-34. doi: 10.1111/jch.12084. Epub 2013 Mar 15. Review.

4.

Posterior mediastinal paraganglioma with bilateral adrenal pheochromocytoma.

Kwon HJ, Park JH, Jin GY, Chung MJ, Lim ST, Kim MH, Kim HJ, Lee YC.

Respir Med. 2004 Jun;98(6):574-6.

PMID:
15191044
5.

SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.

Assadipour Y, Sadowski SM, Alimchandani M, Quezado M, Steinberg SM, Nilubol N, Patel D, Prodanov T, Pacak K, Kebebew E.

Surgery. 2017 Jan;161(1):230-239. doi: 10.1016/j.surg.2016.05.050. Epub 2016 Nov 10.

PMID:
27839933
6.

Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.

Guo Z, Lloyd RV.

Adv Anat Pathol. 2015 Sep;22(5):283-93. doi: 10.1097/PAP.0000000000000086. Review.

PMID:
26262510
7.

Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.

Kim JH, Seong MW, Lee KE, Choi HJ, Ku EJ, Bae JH, Park SS, Choi SH, Kim SW, Shin C, Kim SY.

Clin Genet. 2014 Nov;86(5):482-6. doi: 10.1111/cge.12304. Epub 2013 Nov 15.

PMID:
24134185
8.

Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma.

Rana HQ, Rainville IR, Vaidya A.

Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):166-76. doi: 10.1097/MED.0000000000000059. Review.

PMID:
24739310
9.

Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.

Babic B, Patel D, Aufforth R, Assadipour Y, Sadowski SM, Quezado M, Nilubol N, Prodanov T, Pacak K, Kebebew E.

Surgery. 2017 Jan;161(1):220-227. doi: 10.1016/j.surg.2016.05.059. Epub 2016 Nov 16.

PMID:
27865588
10.

Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.

Pham TH, Moir C, Thompson GB, Zarroug AE, Hamner CE, Farley D, van Heerden J, Lteif AN, Young WF Jr.

Pediatrics. 2006 Sep;118(3):1109-17.

PMID:
16951005
11.

Hereditary pheochromocytoma and paraganglioma.

Mazzaglia PJ.

J Surg Oncol. 2012 Oct 1;106(5):580-5. doi: 10.1002/jso.23157. Epub 2012 May 30. Review.

PMID:
22648936
12.

Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma.

Nakamura E, Kaelin WG Jr.

Endocr Pathol. 2006 Summer;17(2):97-106. Review.

PMID:
17159241
13.

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

Kaltsas GA, Papadogias D, Grossman AB.

Front Horm Res. 2004;31:61-75. Review. No abstract available.

PMID:
14674305
14.

[Hereditary pheochromocytoma-associated syndromes. Part 1].

Yukina MY, Troshina EA, Beltsevich DG.

Ter Arkh. 2015;87(9):102-105. doi: 10.17116/terarkh2015879102-105. Review. Russian.

PMID:
26591561
15.

SDH-related pheochromocytoma and paraganglioma.

Kantorovich V, King KS, Pacak K.

Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):415-24. doi: 10.1016/j.beem.2010.04.001. Review.

16.

A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.

Buffet A, Venisse A, Nau V, Roncellin I, Boccio V, Le Pottier N, Boussion M, Travers C, Simian C, Burnichon N, Abermil N, Favier J, Jeunemaitre X, Gimenez-Roqueplo AP.

Horm Metab Res. 2012 May;44(5):359-66. doi: 10.1055/s-0032-1304594. Epub 2012 Apr 19. Review.

PMID:
22517557
17.

Genetics of pheochromocytoma and paraganglioma: new developments.

Pigny P, Cardot-Bauters C.

Ann Endocrinol (Paris). 2010 Mar;71(2):76-82. doi: 10.1016/j.ando.2009.11.004. Epub 2009 Dec 22. Review.

PMID:
20031114
18.

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.

Welander J, Andreasson A, Juhlin CC, Wiseman RW, Bäckdahl M, Höög A, Larsson C, Gimm O, Söderkvist P.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1352-60. doi: 10.1210/jc.2013-4375. Epub 2014 Apr 2.

19.

Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.

Benn DE, Richardson AL, Marsh DJ, Robinson BG.

Ann N Y Acad Sci. 2006 Aug;1073:104-11. Review.

PMID:
17102077
20.

Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene.

Rich T, Jackson M, Roman-Gonzalez A, Shah K, Cote GJ, Jimenez C.

Fam Cancer. 2015 Dec;14(4):615-9. doi: 10.1007/s10689-015-9821-0. Epub 2015 Jul 11.

PMID:
26162468

Supplemental Content

Support Center